Cajal Neuroscience
- Headquarters
- Seattle, Washington
- Business Model
- B2B
- Website
- cajalneuro.com
- Total Funding
- $96.0M
- Last Round
- $96.0M Series ANov 2022
About
Cajal Neuroscience is a Seattle-based biotechnology company integrating human genetics, functional genomics, and advanced microscopy to discover novel targets and therapeutics for neurodegeneration. Founded in 2021, the company applies computational biology and high-throughput functional validation to understand the mechanistic, spatial, and temporal complexity of neurodegenerative diseases.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account